Quick summary: Pradaxa (dabigatran, previously called Pradax): not to be used in patients with artificial heart valves .
Pradaxa (dabigatran, previously called Pradax): not to be used in patients with artificial heart valves
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Pradaxa (dabigatran, previously called Pradax): not to be used in patients with artificial heart valves .
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
Affected products
Issue
Health Canada is advising health care professionals and the public that, based on new information, the blood-thinning drug Pradaxa is not to be used in patients with artificial heart valves (also known as prosthetic heart valves) due to the risk of strokes, bleeding, heart attacks, and blood clots forming on the artificial heart valves.
What you should do
- Do not stop using Pradaxa or other anticoagulants without guidance from your health care professional. Stopping anticoagulants suddenly may increase your risk of blood clots or a stroke.
- Report any adverse reactions (side-effects) you may have experienced to your health care professional.
Additional official information
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.